Michael Chetrit

Skip the non-contrast CT in #YesCCT aortic valve assessment? CCT indexed aortic valve calcium volume accurately Dx severe AS & predicts valve replacement or death w/out separate non-contrast CT in multicenter registry study jacc.org/doi/10.1016/j.… #JACCIMG #cvImaging #vhdAS

“[Nick Suzuki] is probably the most underrated two-way player in the league…” - HOF Mark Messier on @CBCOlympics after @TeamCanada win over Czechia. @CanadiensMTL Full interview @cbcsports ➡️ shorturl.at/lryFZ #MilanoCortina2026

Jesus, Ivan

Another real-world evaluation of mavacamten in oHCM from a registry (COLLIGO-HCM) showing: 1) Mavacamten is effective in relieving LVOT gradients and improving symptoms. 2) Study had a short term follow up (mean 35 weeks). 3) 60% improvement in NYHA class by 1 FC which was seen in EXPLORER as well. --> we discontinue patients who do not derive symptomatic benefit from commercial mavacamten/CMI 4) Safety consistent with EXPLORER (have to go to text not in the abstract), with somewhat shorter term follow up, as well as certain adjustments to dose initiation (such as some on 2.5 mg). Terminal doses are not mentioned (I could have missed that). 5) Mavacamten effects on LVOTO, NYHA class, and LVEF were somewhat consistent as a monotherapy or when with background medical therapy ahajournals.org/doi/10.1161/CI… #CardioTwitter

M-TEER is also effective for Atrial MR? Yes, it is! From OCEAN cohort #PCRTokyo #LBT #M-TEER @PCRonline @misako_desu @TomokiOchiai

I’m excited to announce the launch of the Inflammatory Myocardial and Pericardial Disease Specialty Interest Group (SIG) within the American Society of Echocardiography (ASE). This SIG will serve as a dedicated platform for medical professionals involved in the diagnosis and management of inflammatory myocardial and pericardial diseases through cardiovascular imaging. This will be a valuable opportunity to learn from leading experts from around the world, share knowledge, and expand professional networking within this growing field. I invite you to consider joining us. As Chair of this SIG, I would like to sincerely thank ASE for supporting this initiative. I am also honored to be joined by Dr. Allan Klein of the Cleveland Clinic as Co-Chair of this group. Finally, I would like to thank the colleagues and committee members who have been willing to support this effort as we begin building this new community. We look forward to growing this collaborative platform together To learn more and join the SIG, please visit: my.asecho.org/get-involved/c… @ASE360 @AllanLKleinMD1 @AbbateAntonio @MerriBremer @MohamedAlKazaz @ChetritMichael @LehtonenJukka @Tahirkafil @SophieMavrogeni @MMukherjeeMD @RichardPalma @Bweber04 @MargaretPark @purviparwani @TomKMWang @DrHebaMD @DavidWienerMD

Excellent paper here by Dr. Sheikh and Dr. Fontana et al. placing CMR ECV within context and clinical usefulness. It is also a reminder that ATTR-CM is a fatal disease. Over 2.8 years, 40% died (enrolled over 13 years). jacc.org/doi/10.1016/j.… #CardioTwitter

Check out our study in @JAHA_AHA on short and long term outcomes of pericarditis, myocarditis and myopericarditis in patients on ICI therapy! Couldn’t have done without @AkivaRosenzveig Thank you, Dr. @AllanLKleinMD1 for the immense support! ahajournals.org/doi/10.1161/JA…

SLAFKOVSKY AGAIN!!! This guy loves international games!🔥

This illustration is misleading as anterior leaflet actually shows a slight prolapse (pseudo prolapse) rather than tethering in atriogenic PML tethering

listen to us discussing the recurrent CV analysis from ATTRibute-CM reachmd.com/programs/on-th… Papar: jacc.org/doi/10.1016/j.… #CardioTwitter

❤️📸 EACVI Imaging Challenge – Case 1 🔍 More than meets the eye! A subtle but very telling finding on functional imaging Submitted by: Aristi Boulmpou 📍 St. Luke’s Hospital, Panorama, Thessaloniki, Greece Co-author: Alexandros Kallifatidis What anatomical finding is shown by the arrow? 1. Coronary sinus dilatation 2. Persistent left SVC 3. Retroaortic anomalous coronary artery 4. Catheter @rafavidalperez @BirkhoelzerS @bisacciaMD @YBououdina @MSBBrandao @ydaryani @Elizabeth_antos @pfelissamburu @CharlesFauvel @alexsfelixecho @galzeranod @andgiannopmd @hrt01a @WilliamKokFaiK1 @M_Marwan_ @drahmedmohsen85 @aniela_petrescu @benayozbay @slumberbell @senguptasp @ElizabetaK10533 @samsrivastava77 @MihaiTrofenciuc @C_VanDeHeyning @drozgeozden @Giulia_Vinco @VazyurVasquez

Mechanical wave analysis via high frame rate #echofirst is a novel, feasible adjunct to standard echo, but has a wide normal range & does not identify subclinical dysfunction. jacc.org/doi/10.1016/j.… #JACCIMG #cvEcho @tom_marwick

🫀 Strain Echo is now mainstream clinical practice New @ASE360 + #EACVI consensus makes GLS essential, not optional. 📌 Abnormal GLS: > –16% 📉 Serial drop 10–15% = significant Where it matters most: ✔️ Cardio-oncology (detects dysfunction before EF falls) ✔️ HF (adds prognosis beyond EF) ✔️ HFpEF & unexplained dyspnea ✔️ Valvular disease risk stratification ✔️ Amyloidosis & cardiomyopathy pattern recognition Bottom line: If you’re not reporting GLS, you’re missing prognostic data. #echofirst #CVImaging @rafavidalperez @YBououdina @MSBBrandao @ydaryani @Elizabeth_antos @pfelissamburu @CharlesFauvel @alexsfelixecho @ElizabetaK10533 @samsrivastava77 @MihaiTrofenciuc @C_VanDeHeyning @drozgeozden @Giulia_Vinco @VazyurVasquez @VDelgadoGarcia @EHJCVIEiC academic.oup.com/ehjcimaging/ad…

Has anyone ever seen anything like this?🧐 (follow the thread) #YesCCT @Heart_SCCT @AChoiHeart @Doc_Tiger @purviparwani @iamritu @onco_cardiology @mmamas1973 @DrRumberger @MarcDweck @CardiacCTGuy @wikimagen

On Canadiens-Sabres: From me, the potential solutions to some nagging problems that led to a Canadiens comeback win: nytimes.com/athletic/70132… From @MatthewFairburn, the Sabres were unhappy it was essentially a road game and other thoughts: nytimes.com/athletic/70131…

The amount of Habs fans sitting in the lower bowl in Buffalo is ridiculous. It’s a sea of red going nuts every Canadiens goal

📽️ January 2026 issue of Circ Imaging is out! EIC Robert Gropler highlights advances in GLS-based risk stratification (ATTR-CM), molecular MRI of fibrosis, streamlined amyloid imaging workflows, valvular staging, coronary CTA for PCI planning, and more. 🔗ahajournals.org/do/10.1161/vid…

Believe it or not, it's almost time for #ASE2026. Abstract submission deadline is fast approaching but has been extended one week to January 21. If you want to highlight your best work to international experts in #EchoFirst, now is your time to act! @ASE360 @ppsengupta1

No better way to celebrate a new year than to publish with my dear friend and inspiring colleague, @MasriAhmadMD commenting on the wonderful work by Debonnaire et al. When @MasriAhmadMD talks, I learn ! ahajournals.org/doi/10.1161/CI…